| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 3, 2026 | Inotiv files for Chapter 11 bankruptcy protection | Please subscribe to IBJ to decode this article.
hau- ytc RI ronweaT.irovnnnsfaafg sWFcpdunenmSaai sogh-amaSs tadrdn o-dtap"—M pu tt e-kdcrihIr d ttaoEirAurEvs ac pSaae grg ogl t bknnenntr foeres,ede=—innTt os acyrtnn ao,hueIr lYoe ohol... |
| Dec 30, 2024 | Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million | WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research mo... |
| Dec 23, 2024 | Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million | WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research mo... |
| Dec 23, 2024 | Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million | WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research mo... |
| Jul 25, 2024 | Inotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024 | WEST LAFAYETTE, Ind., July 25, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services an... |
| Jun 3, 2024 | Corporate breeder that mistreated thousands of beagles pleads guilty, will pay $22 million in fines | Washington — A corporation that breeds and sells animals to the scientific community for testing admitted to knowingly violating federal law when it failed to provide adequate care to thousands of beagles at its Cumberland, Virginia, breedi... |
| Apr 29, 2024 | Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024 | WEST LAFAYETTE, Ind., April 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services a... |
| Dec 6, 2023 | Inotiv, Inc. Announces Plan to Insource North American Transportation Operations | WEST LAFAYETTE, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research mo... |
| Nov 27, 2023 | Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 2023 | WEST LAFAYETTE, Ind., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jul 24, 2023 | Inotiv, Inc. to Report Fiscal 2023 Third Quarter Financial Results and Host Conference Call on Thursday, August 10, 2023 | WEST LAFAYETTE, Ind., July 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Apr 26, 2023 | Inotiv, Inc. to Report Fiscal 2023 Second Quarter Financial Results and Host Conference Call on Thursday, May 11, 2023 | /EIN News/ -- WEST LAFAYETTE, Ind., April 26, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery ... |
| Apr 11, 2023 | Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market | Inotiv offers fit-for-purpose drug testing approaches and quality-by-design methodologies to facilitate sample analysis accuracy, boosting clients' success rates.
SAN ANTONIO, April 11, 2023 /PRNewswire/ -- Recently, Frost & Sulliv... |
| Feb 13, 2023 | Inotiv, Inc. Announces First Quarter Fiscal 2023 Financial Results | Reiterates Select Full Year Fiscal 2023 Financial Guidance
/EIN News/ -- WEST LAFAYETTE, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization ... |
| Dec 12, 2022 | Inotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financial Results | Delays Release of Full Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2022
/EIN News/ -- WEST LAFAYETTE, Ind., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inoti... |
| Dec 12, 2022 | Cambodia halts exports of non-human primates, threatening drug discovery efforts | Following the recent indictments of several people allegedly involved in a monkey-smuggling operation, Cambodia has halted exports of non-human primates that are widely used in pharmaceutical research, a move that may crimp drug discovery e... |
| Dec 5, 2022 | 16 Essential Components Of An Internal Comms Strategy For Teams | Having healthy internal communication on your team is essential for productivity and work output. Employees need access to the tools, systems and training they need to successfully communicate with one another, perform at a high level and g... |
| Aug 31, 2022 | Inotiv, Inc. to Participate in September Investor Conferences | WEST LAFAYETTE, Ind., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Aug 10, 2022 | Inotiv, Inc. Announces Third Quarter Fiscal 2022 Financial Results | WEST LAFAYETTE, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Aug 1, 2022 | Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference Call on Wednesday, August 10, 2022 | WEST LAFAYETTE, Ind., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jul 26, 2022 | Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays at Rockville, MD, Location | WEST LAFAYETTE, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jul 18, 2022 | Envigo Reaches Agreement with the U.S. Department of Justice and the U.S. Department of Agriculture to Resolve Civil and Administrative Complaints | WEST LAFAYETTE, Ind., July 18, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jul 7, 2022 | Inotiv, Inc. Expands Protein/Peptide Bioanalytical Capabilities with Acquisition of Protypia, Inc. | WEST LAFAYETTE, Ind., July 07, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jun 22, 2022 | Glenn Washer Joins Inotiv, Inc., as Group President, Safety Assessment | WEST LAFAYETTE, Ind., June 22, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jun 13, 2022 | Inotiv, Inc. Announces Site Closures and Consolidation Plans | WEST LAFAYETTE, Ind., June 13, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| May 16, 2022 | Inotiv, Inc. to Participate in Upcoming Investor Conferences | WEST LAFAYETTE, Ind., May 16, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development ... |
| May 12, 2022 | Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial Results | WEST LAFAYETTE, Ind., May 12, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development ... |
| Apr 26, 2022 | Inotiv, Inc. to Report Second Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, May 12, 2022 | WEST LAFAYETTE, Ind., April 26, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developmen... |
| Apr 25, 2022 | Inotiv, Inc. Bolsters Pathology Services with Acquisition of Histion, LLC | WEST LAFAYETTE, Ind., April 25, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developmen... |
| Feb 11, 2022 | Inotiv : Announces First Quarter Fiscal 2022 Financial Results - Form 8-K | Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results
WEST LAFAYETTE, IN, February 10, 2022 - Inotiv, Inc. (NASDAQ: NOTV) (the "Company", "We", "Our" or "Inotiv"), "), a leading cont... |
| Feb 11, 2022 | Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results | WEST LAFAYETTE, Ind., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Feb 1, 2022 | Inotiv : Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc - Form 8-K | Inotiv, Inc. Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc.
WEST LAFAYETTE, IN, January 27, 2022 -- Inotiv, Inc. (NASDAQ: NOTV) (the "Company", "We", ... |
| Jan 27, 2022 | Inotiv, Inc. to Report First Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, February 10, 2022 | WEST LAFAYETTE, Ind., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jan 27, 2022 | Inotiv, Inc. Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc. | WEST LAFAYETTE, Ind., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jan 27, 2022 | Inotiv, Inc. Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc. | WEST LAFAYETTE, Ind., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jan 14, 2022 | Inotiv : Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC - Form 8-K | Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC
WEST LAFAYETTE, IN, January 10, 2022 -- Inotiv, Inc. (NASDAQ: NOTV) (the "Company", "We", "Our&q... |
| Jan 10, 2022 | Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC | WEST LAFAYETTE, Ind., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jan 10, 2022 | Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC | WEST LAFAYETTE, Ind., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jan 6, 2022 | Inotiv, Inc. Announces the Acquisition of the Rabbit Breeding and Supply Business of Robinson Services Inc. (“RSI”) | WEST LAFAYETTE, Ind., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jan 6, 2022 | Inotiv, Inc. Announces the Acquisition of the Rabbit Breeding and Supply Business of Robinson Services Inc. (“RSI”) | WEST LAFAYETTE, Ind., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Jan 4, 2022 | Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers | -- Expected to establish a leading global provider of full-spectrum, preclinical and clinical biotherapeutics and biomarker analysis solutions --
-- Expected to enhance scale, broaden customer base and create significant cross-selling oppor... |
| Dec 17, 2021 | Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results | WEST LAFAYETTE, Ind., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Dec 17, 2021 | Inotiv : Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results - Form 8-K | Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results
WEST LAFAYETTE, IN, December 16, 2021- Inotiv, Inc. (NASDAQ: NOTV) (the "Company", "We", "Our" or "Inotiv"), a leading... |
| Dec 16, 2021 | Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results | WEST LAFAYETTE, Ind., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Dec 13, 2021 | Inotiv, Inc. Announces the Launch of New Genetically Engineered Rodent Models for SARS-CoV-2 (COVID-19) Research | WEST LAFAYETTE, Ind., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Dec 13, 2021 | Inotiv, Inc. Reschedules Fourth Quarter Fiscal 2021 Financial Results and Conference Call for Thursday, December 16, 2021 | WEST LAFAYETTE, Ind., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Dec 13, 2021 | Inotiv, Inc. Announces the Launch of New Genetically Engineered Rodent Models for SARS-CoV-2 (COVID-19) Research | WEST LAFAYETTE, Ind., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Dec 8, 2021 | Inotiv : Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021 - Form 8-K | Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results
for the Fourth Quarter and Full Year Fiscal 2021
-- Company To Reschedule Its Financial Results Conference Call --
WEST LAFAYETTE, IN, December 7, 2021 - Inotiv, Inc. (NA... |
| Dec 8, 2021 | Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021 | WEST LAFAYETTE, Ind., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Dec 7, 2021 | Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021 | WEST LAFAYETTE, Ind., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Nov 29, 2021 | Inotiv, Inc. to Report Fourth Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, December 7, 2021 | WEST LAFAYETTE, Ind., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Nov 24, 2021 | Cardiovascular Safety Pharmacology: Best Practice Considerations for the In Vivo QTc Core Assay, Upcoming Webinar Hosted by Xtalks | Register for this webinar to understand how the in vivo QTc assay fits within the ICH guidelines, and how CV safety pharmacology study models are validated and verified.
TORONTO (PRWEB) November 24, 2021
The goal of cardiovascular safety ph... |
| Nov 10, 2021 | Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility | WEST LAFAYETTE, Ind., Nov. 10, 2021 (GLOBE NEWSWIRE) -- November 10, 2021 -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug disc... |
| Nov 10, 2021 | Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility | WEST LAFAYETTE, Ind., Nov. 10, 2021 (GLOBE NEWSWIRE) -- November 10, 2021 -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug disc... |
| Nov 5, 2021 | Inotiv, Inc. Completes Purchase of Envigo | WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contract research organization (CRO) specializing in nonclinical and analytical drug discovery and development serv... |
| Nov 5, 2021 | Inotiv, Inc. Completes Purchase of Envigo | WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contract research organization (CRO) specializing in nonclinical and analytical drug discovery and development serv... |
| Nov 5, 2021 | Inotiv, Inc. Completes Purchase of Envigo | Creates a Full-Spectrum Discovery-to-Approval Solution for Drug Developers
WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contract research organization (CRO) spe... |
| Nov 4, 2021 | Inotiv, Inc. Shareholders Approve Acquisition of Envigo | WEST LAFAYETTE, Ind., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Nov 4, 2021 | Inotiv, Inc. Shareholders Approve Acquisition of Envigo | WEST LAFAYETTE, Ind., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Nov 2, 2021 | Inotiv, Inc. to Participate in Upcoming Investor Conferences | WEST LAFAYETTE, Ind., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Oct 28, 2021 | Clinical Pathology Integration in Nonclinical Toxicity Studies: Pulling It All Together, Upcoming Webinar Hosted by Xtalks | Clinical pathology data interpreted in the context of findings from other study endpoints (e.g., in-life, pathology, toxicokinetics) creates a natural mutual synergy between disciplines, strengthening the overall scientific value of toxicit... |
| Oct 22, 2021 | INOTIV, INC. : Other Events (form 8-K) | Item 8.01. Other Events.
On September 21, 2021, Inotiv, Inc. ("Inotiv" or the "Company"), Dolphin MergeCo, Inc. ("Merger Sub"), Dolphin Merger Sub, LLC ("Merger Sub LLC" and together with Merger Sub, ... |
| Oct 4, 2021 | Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc. | WEST LAFAYETTE, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development ... |
| Sep 27, 2021 | Inotiv : , Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purchase Additional $15 Million of Notes | WEST LAFAYETTE, Ind., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Sep 21, 2021 | Inotiv : and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions (Form 8-K) | Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
-- Expected to establish a leading global provider of a full spectrum of pre-clinical solutions --
-- Expected to be immediately accretive to In... |
| Sep 21, 2021 | Inotiv : and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions | -- Expected to establish a leading global provider of a full spectrum of pre-clinical solutions --
-- Expected to be immediately accretive to Inotiv earnings and margins before synergies --
-- Expected to enhance scale, broaden customer bas... |
| Aug 18, 2021 | Inotiv : 3rd Qtr 10Q | UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
for the quarterly period ended June 30, 2021
OR
TRANSITION ... |
| Aug 11, 2021 | Inotiv : Announces Third Quarter Fiscal 2021 Financial Results (Form 8-K) | Inotiv, Inc. Announces Third Quarter Fiscal 2021 Financial Results
WEST LAFAYETTE, IN, August 11, 2021 - Inotiv, Inc. (NASDAQ: NOTV) (the 'Company', 'We', 'Our' or 'Inotiv'), a leading contract resear... |
| Aug 11, 2021 | Inotiv : Announces Third Quarter Fiscal 2021 Financial Results | WEST LAFAYETTE, Ind., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| May 27, 2021 | INOTIV, INC.
Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity | WEST LAFAYETTE, Ind., May 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development s... |
| May 5, 2021 | INOTIV, INC.
Inotiv : Announces Second Quarter Fiscal 2021 Financial Results | WEST LAFAYETTE, Ind., May 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development s... |
| Apr 30, 2021 | INOTIV, INC.
Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc. | WEST LAFAYETTE, Ind., April 30, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Apr 23, 2021 | INOTIV, INC.
Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares | WEST LAFAYETTE, Ind., April 23, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Apr 21, 2021 | INOTIV, INC.
Inotiv, Inc. Announces Proposed Public Offering of Common Shares | WEST LAFAYETTE, Ind., April 20, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Apr 21, 2021 | INOTIV, INC.
Inotiv, Inc. Announces Pricing of Public Offering of 2,647,059 Common Shares | WEST LAFAYETTE, Ind., April 21, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Apr 21, 2021 | INOTIV, INC.
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021 | WEST LAFAYETTE, Ind., April 20, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Apr 19, 2021 | INOTIV, INC.
Inotiv, Inc. Announces Plan to Expand the Company's Internal Operations | WEST LAFAYETTE, Ind., April 19, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development... |
| Apr 16, 2021 | INOTIV, INC.
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc. | WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research services, today announced that the Company has... |
| Apr 6, 2021 | INOTIV, INC.
Inotiv, Inc. Announces Partnership with PhoenixBio Co., Ltd. to Expand Discovery Pharmacology Offering | WEST LAFAYETTE, Ind., April 06, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research services, today announced an agreement to partn... |
| Mar 17, 2021 | Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology | WEST LAFAYETTE, Ind., March 17, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research servic... |
| Mar 9, 2021 | Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Additional Vivarium Capacity at Facility in West Lafayette, IN | WEST LAFAYETTE, Ind., March 09, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research servic... |
| Mar 4, 2021 | Bioanalytical Systems, Inc., doing business as Inotiv, to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference | WEST LAFAYETTE, Ind., March 04, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research servic... |
| Feb 24, 2021 | Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Laboratory Infrastructure and Data and Study Management Technologies | WEST LAFAYETTE, Ind., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research service... |
| Feb 11, 2021 | Bioanalytical Systems, Inc., doing business as Inotiv, Appoints Greg Beattie as Chief Operating Officer | WEST LAFAYETTE, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research service... |
| Jan 11, 2021 | Daniel Smeak, DVM, ACVS, Joins Inotiv as Vice President, Surgical Models | WEST LAFAYETTE, Ind., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research... |
